Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study

NCT00225017 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection
Hyperlipidemia

Interventions

DRUG: Atazanavir
DRUG: current antiretroviral regimen

Sponsor

Northwestern University

Collaborators

[object Object]